Rice Steven J. 4
4 · Vir Biotechnology, Inc. · Filed Dec 2, 2021
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-30−10,000→ 424,441 totalExercise: $12.76Exp: 2029-12-10→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-11-30$50.00/sh−10,000$500,000→ 20,600 total - Exercise/Conversion
Common Stock
2021-11-30$12.76/sh+10,000$127,600→ 30,600 total
Footnotes (3)
- [F1]Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
- [F3]1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.